Dr Reddy's Dominates with Generic Ozempic Approval!

Dr Reddy's just scored a major victory! They’ve snagged approval to unleash their generic Ozempic, ready to tackle diabetes like a true champion. With 12 million Semaglutide pens primed for launch, they’re flexing a 19% revenue rise despite a minor profit dip. And Canada? They’re coming for you too! Can you feel the electrifying energy of Dr Reddy's? It's time to lay the smackdown!